Literature DB >> 3256505

Behaviour of intraocular gases.

P M Jacobs1, J M Twomey, P K Leaver.   

Abstract

The changes in volume of intraocular bubbles of air, sulphur hexafluoride, perfluoropropane and mixtures of these gases, were studied in human eyes, following vitrectomy for treatment of retinal detachment. The implications of these findings, for the provision of optimal internal tamponade in the treatment of retinal detachment, are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3256505     DOI: 10.1038/eye.1988.121

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  Duration of intraocular gases following vitreoretinal surgery.

Authors:  Andreas Kontos; James Tee; Alastair Stuart; Zaid Shalchi; Tom H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-26       Impact factor: 3.117

2.  Management of orbital emphysema secondary to rhegmatogenous retinal detachment repair with hyperbaric oxygen therapy.

Authors:  Dante L Iniesta-Sanchez; Fatima Romero-Caballero; Adriana Aguirre-Alvarado; Victoria Rebollo-Hurtado; Raul Velez-Montoya
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-19

3.  Outcome of 2 cc pure sulfur hexafluoride gas tamponade for macular hole surgery.

Authors:  Naresh B Kannan; Olukorede O Adenuga; Karthik Kumar; Kim Ramasamy
Journal:  BMC Ophthalmol       Date:  2016-06-03       Impact factor: 2.209

4.  Primary rhegmatogenous retinal detachment with inferior retinal breaks postoperative prone positioning results: 1 day versus 7 days.

Authors:  Radwan Ajlan; Jordan Isenberg; Ghassan Cordahi; Renaud Duval; Sébastien Olivier; Flavio Rezende
Journal:  Int J Retina Vitreous       Date:  2017-12-04

5.  Objective analysis of perfluoropropane tamponade area after pars plana vitrectomy using ultra-widefield fundus stereographic projection images.

Authors:  Mihyun Choi; Suji Hong; Cheolmin Yun; Seong-Woo Kim
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.